In BRAF or RAS mutant tumor cells, DUSP4, DUSP6, SPRY2, and SPRY4 tend to be highly expressed, allowing tumors to evade regular MAPK signaling pathway feedback (Pratilas et al., 2009). The gene discussed is BRAF; the disease is neoplasm.